Patents by Inventor David PÉREZ

David PÉREZ has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200117631
    Abstract: An automated device discovery system includes a chassis defining device slots, with device connectors located adjacent each of the device slots. A bus subsystem and a reset subsystem are coupled to the device connectors. A processing system, which is coupled to each of the at least one bus system and the reset subsystem, causes the reset subsystem to sequentially assert reset instructions through each of the device connectors in a device slot sequence. The processing system then sequentially detects, via bus paths in the bus subsystem, each device that is located in one the device slots and coupled to its respective device connector based on reset operations performed by that device in response to the sequentially asserted reset instructions. The processing system then maps each device that was detected with a respective device slot identifier that corresponds to the device slot sequence in which the reset instructions were asserted.
    Type: Application
    Filed: October 12, 2018
    Publication date: April 16, 2020
    Inventors: Alberto David Perez Guevara, Jeffrey L. Kennedy
  • Patent number: 10602475
    Abstract: The embodiments of the disclosure relates to a device location manager for a communication system, the device location manager comprising: a southbound interface configured to receive a physical location information of a mobile device from an infrastructure manager of the communication system, a location processor configured to map between the physical location information and a logical location information, and a northbound interface configured to send and/or receive the logical location information to and/or from at least two network slices of the communication system.
    Type: Grant
    Filed: March 4, 2019
    Date of Patent: March 24, 2020
    Assignee: HUAWEI TECHNOLOGIES CO., LTD.
    Inventors: Qing Wei, David Perez Caparros, Xueli An
  • Patent number: 10527324
    Abstract: The invention relates to the design of an air cooled absorption machine. Said machine has a hollow design via which air can circulate inside same by forced convention having a parallelepiped form. The air enters by suction via the sides and leaves via the upper face of the machine, where the ventilator is located. The machine comprises falling-film heat exchangers with improved designs for heat and mass transfer.
    Type: Grant
    Filed: June 6, 2014
    Date of Patent: January 7, 2020
    Assignee: Universitat Politècnica de Catalunya
    Inventors: Asensio Oliva Llena, Carlos David Pérez Segarra, Joaquim Rigola Serrano, Jesús Castro González, Carles Oliet Casasayas, Ivette Rodríguez Pérez, Oriol Lehmkuhl Barba, Xavi Trias Miquel, Roser Capdevila Paramio, Ramiro Alba Queipo, Manuel Miguel Ordoño Martinez, Joan Farnos Baluenas
  • Patent number: 10481935
    Abstract: A virtual server for executing a communication process is implemented on virtualization resources without being inefficient even when different virtualization resource management schemes are included. A management system included in a mobile communication system is configured to include an NFVI which is virtualization resources including a physical server in which a VNF to execute a communication process is generated and includes a VNFM for managing the VNF, a VIM for managing the virtualization resources of the NFVI, and an orchestrator for managing all the virtualization resources of the NFVI, wherein the orchestrator includes a virtual server generation request section configured to input detailed information for implementing the VNF retained by the VNFM, rewrite the input detailed information according to a virtualization resource management scheme by the VIM, and request the VIM to generate the VNF.
    Type: Grant
    Filed: December 25, 2014
    Date of Patent: November 19, 2019
    Assignee: NTT DOCOMO, INC.
    Inventors: Shigeru Iwashina, Takashi Shimizu, Motoshi Tamura, Tetsuya Nakamura, Hidenori Asaba, Ashiq Khan, Takahiro Yamazaki, Takeo Yamasaki, Joan Triay Marques, David Perez Caparros, Bertrand Souville
  • Patent number: 10481953
    Abstract: Leakage of detailed information for implementing a virtual server to execute a communication process on virtualization resources is prevented. There is provided a management system (10) included in a mobile communication system (1) configured to include an NFVI (60) which is virtualization resources including a physical server generated by a VNF (70) to execute a communication process, and the system includes a VNFM (30) for managing the VNF (70), a VIM (40) for managing the virtualization resources of the NFVI (60), an orchestrator (20) for managing all the virtualization resources of the NFVI (60), wherein the VNFM (30) includes a retention section (31) configured to retain detailed information for implementing the VNF (70) and a virtual server generation request section (32) configured to request the VIM (40) to generate the VNF (70) using the detailed information.
    Type: Grant
    Filed: December 25, 2014
    Date of Patent: November 19, 2019
    Assignee: NTT DOCOMO, INC.
    Inventors: Shigeru Iwashina, Takashi Shimizu, Motoshi Tamura, Tetsuya Nakamura, Hidenori Asaba, Ashiq Khan, Takahiro Yamazaki, Takeo Yamasaki, Joan Triay Marques, David Perez Caparros, Bertrand Souville
  • Patent number: 10474612
    Abstract: A lane reversal detection and bifurcation system includes an interface that includes a plurality of lanes that are coupled to an endpoint interface of an endpoint device and a BIOS that bifurcates the interface into a first root port and a second root port, such that the first root port is coupled to a first subset of the plurality of lanes, and the second root port is coupled to a second subset of the plurality of lanes. The BIOS initializes the endpoint device to establish a link between the endpoint device and the interface. The BIOS detects an endpoint presence and a non-functional link at the first root port and an endpoint presence and a functional link at the second root port and, in response, determines that the first subset of the plurality of lanes coupled to the endpoint device are subject to a lane reversal.
    Type: Grant
    Filed: October 30, 2018
    Date of Patent: November 12, 2019
    Assignee: Dell Products L.P.
    Inventors: Alberto David Perez Guevara, Wei G. Liu
  • Patent number: 10377758
    Abstract: The present invention relates to co-crystals of ibrutinib, a pharmaceutical composition comprising the same as well as a method of preparing the same.
    Type: Grant
    Filed: March 23, 2016
    Date of Patent: August 13, 2019
    Assignee: Ratiopharm GmbH
    Inventors: Wolfgang Albrecht, Jens Geier, Sebastian Rabe, David Perez Palacios
  • Publication number: 20190225616
    Abstract: The present invention relates to co-crystals of ibrutinib and a pharmaceutical composition comprising the same as well as a method of preparing the same.
    Type: Application
    Filed: November 28, 2018
    Publication date: July 25, 2019
    Applicant: ratiopharm GmbH
    Inventors: Wolfgang Albrecht, Jens Geier, Sebastian Rabe, David Perez Palacios
  • Publication number: 20190200316
    Abstract: The embodiments of the disclosure relates to a device location manager for a communication system, the device location manager comprising: a southbound interface configured to receive a physical location information of a mobile device from an infrastructure manager of the communication system, a location processor configured to map between the physical location information and a logical location information, and a northbound interface configured to send and/or receive the logical location information to and/or from at least two network slices of the communication system.
    Type: Application
    Filed: March 4, 2019
    Publication date: June 27, 2019
    Inventors: Qing WEI, David PEREZ, Xueli AN
  • Publication number: 20190199622
    Abstract: This embodiments of the invention relates to a data packet forwarding unit (202) configured to forward data packets within a data transmission network on the basis of data packet forwarding rules, wherein the data transmission network comprises a control plane and a separate data plane. The data packet forwarding unit (202) comprises a storage unit (202b) configured to store at least one of data transmission profiles, wherein each data transmission profile comprises at least one data packet forwarding rule, and a processor (202a) configured to select a data transmission profile from the at least one data transmission profiles and to forward data packets within the data transmission network on the basis of the at least one data packet forwarding rule of the selected data transmission profile.
    Type: Application
    Filed: February 26, 2019
    Publication date: June 27, 2019
    Applicant: HUAWEI TECHNOLOGIES CO., LTD.
    Inventors: Ishan VAISHNAVI, David Perez, Qing Wei
  • Publication number: 20190187048
    Abstract: A system for detecting a disease agent in a sample derived from a patient biofluid may comprise a receiver coupled to a communication network and a controller coupled to the receiver. The controller may comprise a processor and a memory. The controller may be configured to generate an infrared spectrum of the sample. The sample spectrum may comprise one or more sample spectral components, the sample spectral components comprising a sample wavenumber and a sample absorbance value. A set of reference spectral models may comprise one or more reference spectral components. The reference spectral components may comprise a reference wavenumber and a reference absorbance value. The reference spectral components may comprise one or more pathogen characteristics associated with sepsis. The one or more sample spectral components may be classified as pathogenic using the reference spectral models. Pathogen data may be generated using the classified sample spectral components.
    Type: Application
    Filed: August 19, 2017
    Publication date: June 20, 2019
    Inventors: Bayden Robert Wood, Philip Robert Heraud, David Perez Guaita, Kamila Natalia Kochan
  • Publication number: 20190145952
    Abstract: The invention principally relates to a method of detecting a disease agent in blood, comprising: (i) creating a sample infra-red spectrum representative of the blood, with one or more spectral components, each having a wavenumber and absorbance value; (ii) providing a reference database of spectral models, each model having one or more database spectral components of a wavenumber and an absorbance value, wherein the database spectral components identify disease agents; (iii) determining whether one or more database spectral components corresponds to one or more sample spectral components, and (iv) compiling a list of corresponding database components identified.
    Type: Application
    Filed: December 3, 2018
    Publication date: May 16, 2019
    Applicant: MONASH UNIVERSITY
    Inventors: Bayden R. WOOD, Phillip HERAUD, David PEREZ-GUAITA
  • Publication number: 20190093002
    Abstract: The invention relates to process for preparing an internal olefin sulfonate, comprising: a) sulfonating an internal olefin to produce a first sulfonated internal olefin mixture; and b) contacting the first sulfonated internal olefin mixture with water, caustic and a non-ionic surfactant to form a neutralized sulfonated internal olefin mixture wherein greater than 10 wt. % of the non-ionic surfactant is added.
    Type: Application
    Filed: November 21, 2018
    Publication date: March 28, 2019
    Inventors: Michael Joseph Doll, Lori Ann Crom, David Perez-Regalado
  • Publication number: 20190031741
    Abstract: The present invention provides fully human antibodies that bind to respiratory syncytial virus F protein, compositions comprising the antibodies and methods of use. The antibodies of the invention are useful for preventing fusion of the virus with the cell membrane and preventing cell to cell spread of the virus, thereby providing a means of preventing the infection, or treating a patient suffering from the infection and ameliorating one or more symptoms or complications associated with the viral infection. The antibodies may also be useful for diagnosis of an infection by RSV.
    Type: Application
    Filed: October 15, 2018
    Publication date: January 31, 2019
    Inventors: Anne Gurnett-Bander, David Perez-Caballero, Sumathi Sivapalasingam, Xunbao Duan, Douglas MacDonald
  • Publication number: 20190017922
    Abstract: In the operation of analytical devices, and particularly laser induced breakdown spectroscopy (LIBS) devices, a number of advantages may be obtained by the use of complementary safety mechanisms, such as those that govern the operation or firing of a laser. Such complementary safety mechanisms, compared to the individual safety mechanisms acting alone, prevent operation of the laser under a greater number of unsafe circumstances (even if one or more detected conditions are safe, based on not activating the associated safety mechanism) and permits operation under a greater number of safe circumstances (even if one or more detected conditions are unsafe, based on activating the associated safety mechanism).
    Type: Application
    Filed: July 16, 2018
    Publication date: January 17, 2019
    Inventors: Michael BUSH, Eric A. MARTIN, David PEREZ, Michael HARGREAVES, Lin ZHANG, Xiaofeng TAN
  • Patent number: 10148416
    Abstract: Embodiments are generally directed to signal phase optimization in memory interface training. An embodiment of an apparatus includes an interface for at least one signal; and interface training logic capable of automatically adjusting a phase relationship between the signal and a strobe or clock, including establishing a phase delay of the signal and a phase delay of the strobe or clock for training of the interface, wherein the interface training logic is capable of determining a phase delay reduction for the signal subsequent to measurement of an eye margin for the signal, the phase delay reduction to retain a sufficient delay to maintain the eye margin for sampling of the signal.
    Type: Grant
    Filed: September 2, 2016
    Date of Patent: December 4, 2018
    Assignee: Intel Corporation
    Inventors: Tonia G Morris, Ying Zhou, John V. Lovelace, Alberto David Perez Guevara
  • Patent number: 10145839
    Abstract: The invention principally relates to a method of detecting a disease agent in blood, comprising: (i) creating a sample infra-red spectrum representative of the blood, with one or more spectral components, each having a wavenumber and absorbance value; (ii) providing a reference database of spectral models, each model having one or more database spectral components of a wavenumber and an absorbance value, wherein the database spectral components identify disease agents; (iii) determining whether one or more database spectral components corresponds to one or more sample spectral components; and (iv) compiling a list of corresponding database components identified.
    Type: Grant
    Filed: October 23, 2015
    Date of Patent: December 4, 2018
    Assignee: Monash University
    Inventors: Bayden R. Wood, Philip Heraud, David Perez-Guaita
  • Publication number: 20180341497
    Abstract: An information handling system includes a memory and a central processing unit. The memory stores a boot image for a boot process of the information handling system. The central processing unit loads the boot image and executes the boot process. During the boot process, the central processing unit performs a pre-EFI initialization phase that configures a socket of the central processing unit during an auto-discovery of the socket, and stores the socket configuration in a memory.
    Type: Application
    Filed: May 25, 2017
    Publication date: November 29, 2018
    Inventor: Alberto David Perez Guevara
  • Patent number: 10125188
    Abstract: The present invention provides fully human antibodies that bind to respiratory syncytial virus F protein, compositions comprising the antibodies and methods of use. The antibodies of the invention are useful for preventing fusion of the virus with the cell membrane and preventing cell to cell spread of the virus, thereby providing a means of preventing the infection, or treating a patient suffering from the infection and ameliorating one or more symptoms or complications associated with the viral infection. The antibodies may also be useful for diagnosis of an infection by RSV.
    Type: Grant
    Filed: August 5, 2016
    Date of Patent: November 13, 2018
    Assignee: Regeneron Pharmaceuticals, Inc.
    Inventors: Anne Gurnett-Bander, David Perez-Caballero, Sumathi Sivapalasingam, Xunbao Duan, Douglas MacDonald
  • Patent number: D850656
    Type: Grant
    Filed: March 13, 2017
    Date of Patent: June 4, 2019
    Assignee: Stockton Products
    Inventor: David Perez